AGATA MARIA SMOGORZEWSKA, MD PHD
Medical Practice at Fruit St, Boston, MA
License number
Massachusetts 217637
Category
Medical Practice
Type
Clinical Pathology/Laboratory Medicine
Address
Address
55 Fruit St, Boston, MA 02114
Phone
(617) 304-2031
Professional information
See more information about AGATA MARIA SMOGORZEWSKA at trustoria.com
Dr. Agata M Smogorzewska, Boston MA - MD (Doctor of Medicine)
Dr. Agata M Smogorzewska, Boston MA - MD (Doctor of Medicine)
Specialties:
Anatomic & Clinical Pathology
Address:
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
(617) 726-2000 (Phone), (617) 726-5715 (Fax)
55 Fruit St, Boston 02114
(617) 304-2031 (Phone)
55 Fruit St, Boston 02114
(617) 304-2031 (Phone)
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
(617) 726-2000 (Phone), (617) 724-5843 (Fax)
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
(617) 726-2000 (Phone), (617) 726-7474 (Fax)
55 Fruit St, Boston 02114
(617) 726-2000 (Phone), (617) 726-5715 (Fax)
55 Fruit St, Boston 02114
(617) 304-2031 (Phone)
55 Fruit St, Boston 02114
(617) 304-2031 (Phone)
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
(617) 726-2000 (Phone), (617) 724-5843 (Fax)
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
(617) 726-2000 (Phone), (617) 726-7474 (Fax)
Languages:
English
Hospitals:
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
55 Fruit St, Boston 02114
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
MASSACHUSETTS GENERAL HOSPITAL
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
J & S Weill M C Cornell Univ
Graduated: 1999
J & S Weill M C Cornell Univ
Graduated: 1999
Agata Maria Smogorzewska, Boston MA
Agata Maria Smogorzewska, Boston MA
Specialties:
Clinical Pathology/Laboratory Medicine
Work:
Wrn 2
55 Fruit St, Boston, MA 02114
55 Fruit St, Boston, MA 02114
Prognostic, Diagnostic, And Cancer Therapeutic Uses Of Fanci And Fanci Modulating Agents
Prognostic, Diagnostic, And Cancer Therapeutic Uses Of Fanci And Fanci Modulating Agents
US Patent:
2013028, Oct 24, 2013
Filed:
Mar 6, 2012
Appl. No.:
13/413129
Inventors:
Alan D. D'Andrea - Winchester MA, US
Patrizia Vinciguerra - Boston MA, US
Stephen J. Elledge - Brookline MA, US
Shuhei Matsuoka - Brookline MA, US
Agata M. Smogorzewska - Boston MA, US
Kay O. Hofmann - Koeln, DE
Patrizia Vinciguerra - Boston MA, US
Stephen J. Elledge - Brookline MA, US
Shuhei Matsuoka - Brookline MA, US
Agata M. Smogorzewska - Boston MA, US
Kay O. Hofmann - Koeln, DE
Assignee:
Miltenyi Biotec GmbH - Bergisch-Gladbach
The Brigham & Women's Hospital, Inc. - Boston MA
The Brigham & Women's Hospital, Inc. - Boston MA
International Classification:
G01N 33/68, G01N 33/50, C07K 16/18, A61K 31/713, A61K 45/06, C12N 9/10, A61K 39/395, C12Q 1/68, C12N 15/113
US Classification:
4241391, 435 71, 435 792, 435 611, 435 32, 514 44 A, 435 61, 435193, 536 245
Abstract:
Disclosed herein are methods and compositions for the treatment of cancer. In particular, the present invention identifies and characterizes the FANCI polypeptide as a vital component of the Fanconi anemia pathway and discloses inhibitors of FANCI and methods of using same. Such inhibitors are useful in inhibiting DNA damage repair and can be useful, for example, in the treatment of cancer.
Prognostic, Diagnostic, And Cancer Therapeutic Uses Of Fanci And Fanci Modulating Agents
Prognostic, Diagnostic, And Cancer Therapeutic Uses Of Fanci And Fanci Modulating Agents
US Patent:
2009008, Mar 26, 2009
Filed:
Mar 10, 2008
Appl. No.:
12/075162
Inventors:
Alan D. D'Andrea - Winchester MA, US
Patrizia Vinciguerra - Boston MA, US
Stephen J. Elledge - Brookline MA, US
Shuhei Matsuoka - Brookline MA, US
Agata M. Smogorzewska - Boston MA, US
Kay O. Hofmann - Koeln, DE
Patrizia Vinciguerra - Boston MA, US
Stephen J. Elledge - Brookline MA, US
Shuhei Matsuoka - Brookline MA, US
Agata M. Smogorzewska - Boston MA, US
Kay O. Hofmann - Koeln, DE
Assignee:
Dana-Farber Cancer Institute - Boston MA
International Classification:
A61K 39/395, C12Q 1/68, G01N 33/53, C07K 14/00, C07K 7/08, A61P 35/00, C07H 21/04, C12Q 1/02
US Classification:
4241721, 435 6, 435 29, 435 71, 536 231, 530402
Abstract:
Disclosed herein are methods and compositions for the treatment of cancer. In particular, the present invention identifies and characterizes the FANCI polypeptide as a vital component of the Fanconi anemia pathway and discloses inhibitors of FANCI and methods of using same. Such inhibitors are useful in inhibiting DNA damage repair and can be useful, for example, in the treatment of cancer.